Evidence map›Paper›PMID 34480614›Full record

ArticleAnnals of hematology2022

A rare de novo pure erythroid leukemia with JAK2 R683S mutation.

Rebecca Z Xu, Aly Karsan, Zhaodong Xu, Brian R Berry

Abstract readCase ReportsLetter
PubMed Publisher
In one paragraph

Article in Annals of hematology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. How Genomic and Structural Context Could Shape JAK-STAT Variant Pathogenicity.Twin research and human genetics : the official journal of the International Society for Twin Studies · 2026
    Article
  2. Article
  3. Review
  4. Autopsy findings of acute erythroid leukemia.Autopsy & case reports · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rebecca Z XuUniversity of British Columbia Medical School, Vancouver, British Columbia, Canada.
Aly KarsanUniversity of British Columbia Medical School, Vancouver, British Columbia, Canada.
Zhaodong XuDepartment of Pathology and Laboratory Medicine, Division of Hematopathology, Royal Jubilee Hospital, 5th floor, 1952 Bay Street, British Columbia, V8R 1J8, Victoria, Canada. zhaodong.xu@viha.ca.ORCID http://orcid.org/0000-0002-4729-4734
Brian R BerryDepartment of Pathology and Laboratory Medicine, Division of Hematopathology, Royal Jubilee Hospital, 5th floor, 1952 Bay Street, British Columbia, V8R 1J8, Victoria, Canada. Brian.Berry@viha.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Erythroblastic, AcuteHumansJanus Kinase 2MutationJAK2 protein, humanJanus Kinase 2

Identifiers

PMID34480614

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.